The Data
/
Stocks
/ A
Equity · Healthcare
A
NYSE
Agilent Technologies, Inc.
$170.45
+1.37% vs prior close
Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 9, 2026
1D
1M
3M
1Y
5Y
All
Price · Chart
63 sessions
The line runs $135.27 on 14 July through $170.45 on 9 October, on a scale from $120 to $180. Days the market did not trade hold the previous close, flat.
Interactive A price chart by TradingView (requires JavaScript).
Market cap
$48.1B
52-week range
$110.21 – $175.27
Avg volume
143.9K
as of Oct 9, 2026
About Agilent Technologies, Inc.
Agilent Technologies, Inc. is a global provider of instruments, software, services, and consumables for laboratory workflows in the life sciences, diagnostics, and applied markets. The company operates through three segments: Life Sciences and Diagnostics Markets (offering contract development and manufacturing services, reagents, instruments, and software for pharmaceutical, clinical, and research customers), Agilent CrossLab (providing services, consumables, software, and laboratory automation solutions), and Applied Markets (supplying instruments and software for analyzing physical and biological properties of substances).
Company
CEO
Padraig McDonnell
Founded
1999
Employees
17,671
Headquarters
Santa Clara
Exchange
NYSE
Sector
Healthcare
Class
Equity
Insiders Form 4
Filings 5 sets
A insider trades
SEC Form 4 · last 90 days · newest reported trade 4 Sep 2026
Open-market buys
0
Open-market sells
1
Net sold
$96K
Non-trade filings
1
Date
Insider
Type
Shares
Value
04 Sep 2026
Dolsten Mikael
Director
Sell
634
$96K
Compensation mechanics
Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Date
Insider
Type
Shares
Value
08 Sep 2026
Boehnlein Glenn S
Director
Award
817
$120K
A reported financials
SEC EDGAR XBRL
SEC EDGAR
A reported revenue of $6.9B for the fiscal year ended 31 Oct 2025. Net income over the same period was $1.3B.
Figure
Reported
Period
Revenue
$6.9B
31 Oct 2025
fiscal year
Net income
$1.3B
31 Oct 2025
fiscal year
Diluted EPS
$4.57
31 Oct 2025
fiscal year
Total assets
$14.0B
31 Jul 2026
at period end
Total equity
$7.4B
31 Jul 2026
at period end
A earnings
SEC EDGAR
Date
Period
EPS
Revenue
31 Jul 2026
Q3 2026
$1.28
—
30 Apr 2026
Q2 2026
$1.20
—
31 Jan 2026
Q1 2026
$1.07
—
31 Oct 2025
FY 2025
$4.57
—
31 Jul 2025
Q3 2025
$1.18
—
30 Apr 2025
Q2 2025
$0.75
—
31 Jan 2025
Q1 2025
$1.11
—
31 Oct 2024
FY 2024
$4.43
—
Next report no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
11 of the 45 institutional funds we track reported a A position for the quarter ended 30 Jun 2026 — a combined $1.3B; the latest of those filings landed 02 Sep 2026.
Fund
Action
Shares
Value
Man Group
Held (±25%)
+1.3% shares
1,349,523
$179.3M
Showing the 10 largest of 11 reported positions. The figures above count all of them.
A fails-to-deliver
SEC CNS data
SEC
On 08 Sep 2026, 596 shares of A failed to deliver (about $90K).
Settlement date
Shares failed
Notional
% of shares out
08 Sep 2026
596
$90K
<0.001%
02 Sep 2026
24
$4K
<0.001%
The most recent congressional trade disclosed in A is a sale by Julie Johnson (house, TX), dated 23 Sep 2025.
Date
Member
Type
Amount
23 Sep 2025
filed 05 Aug 2026
Julie Johnson
house · Democrat–TX
Sale
$1K–$15K
16 Jul 2025
filed 13 Aug 2025
Lisa C. McClain
house · Republican–MI
Sale
$1K–$15K
17 Jun 2025
filed 13 Aug 2025
Lisa C. McClain
house · Republican–MI
Purchase
$1K–$15K
15 May 2025
filed 31 May 2025
Robert P. Bresnahan, Jr.
house · Republican–PA
Purchase
$1K–$15K
17 Apr 2025
filed 08 May 2025
Jefferson Shreve
house · Republican–IN
Purchase
$15K–$50K
08 Apr 2025
filed 28 Apr 2025
Robert P. Bresnahan, Jr.
house · Republican–PA
Sale
$1K–$15K
01 Apr 2025
filed 14 May 2025
Julie Johnson
house · Democrat–TX
Sale
$1K–$15K
13 Mar 2025
filed 11 Apr 2025
Jefferson Shreve
house · Republican–IN
Sale
$15K–$50K
Sources
Finazon prior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
TradingView the price chart widget, drawn by TradingView from their own data
SEC EDGAR SEC EDGAR XBRL company facts · latest period ended 31 Jul 2026
SEC EDGAR SEC EDGAR 13F filings
SEC SEC fails-to-deliver (CNS) data
House disclosures U.S. House of Representatives financial disclosures
SEC EDGAR Valuation computed from SEC EDGAR filings